mdlinx mdlinx
Latest (53) Full Text Articles (2496) Focus on Seizures and Epilepsy Article Summary

Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study
Headache: The Journal of Head and Face Pain,  Clinical Article

Derosier F et al. – This study primarily included subjects whose migraines significantly impacted their lives. Before the study, these subjects used butalbital–containing medications as part of their current migraine treatment regimen and were satisfied with it, suggesting they were butalbital responders who had found a workable treatment strategy for themselves. When treated with SumaRT/Nap versus BCM in this study, however, a significant proportion of subjects reported better treatment outcomes for themselves for both migraine pain and associated symptoms. Use of SumaRT/Nap was also associated with less rescue medication use and a longer time before use of rescue medication compared with both BCM and placebo.

Methods
  • Enrolled subjects were required to have treated at least 1 migraine with a butalbital medication in the past.
  • Enrolled subjects treated 3 moderate to severe migraines using each of the 3 study treatments once in a randomized sequence.
  • The primary endpoint compared SumaRT/Nap versus BCM for sustained pain freedom at 2–24 hours without the use of any rescue medication.
  • This study combines data from 2 identical outpatient, randomized, multicenter, double–blind, double–dummy, 3 attack crossover studies in adult migraineurs (International Classification of Headache Disorders, 2nd edition).

Results
  • A total of 442 subjects treated at least 1 attack with study medication.
  • The majority of the treated subjects were female (88%) with a mean age 43 years, who reported that their migraines had a severe impact on their lives (78% with Headache Impact Test–6 of >59).
  • At screening, 88% of subjects reported current butalbital use; 68% had used butalbital for more than 6 weeks; and 82% reported satisfaction with butalbital.
  • Across treatment groups, 28–29% of subjects took study medication within 15 minutes of migraine onset, 34–37% of subjects took study medication >15 minutes to 2 hours after onset, and 32–36% of subjects took study medication more than 2 hours after onset.
  • This study did not detect a difference at the nominal 0.05 level in percent sustained pain–free between SumaRT/Nap (8%), BCM (6%), and placebo (3%).
  • SumaRT/Nap was superior to BCM for pain free at 2, 4, 6, 8, 24, 48 hours (P ≤ .044); pain relief (mild or no pain) at 2, 4, 6, 8, 24, 48 hours (P ≤ .01); sustained pain relief 2–24 hours (P < .001); migraine free (pain free with no nausea, photophobia, or phonophobia) at 4, 6, 8, 24, 48 hours (P ≤ .046); and complete symptom free (migraine free with no neck/sinus pain) at 4, 6, 8, 48 hours (P ≤ .031).
  • Adverse event incidence was similar for all treatments (10%, 12%, and 9% for placebo, SumaRT/Nap, and BCM, respectively).
  • Nausea was the most frequent adverse event (2%, 2%, and <1% for placebo, SumaRT/Nap, and BCM, respectively).
  • Five serious adverse events were reported by 3 subjects: viral meningitis and colon neoplasm (placebo); chest pain and hypertension 17 days postdose (SumaRT/Nap); and breast cancer (BCM).
  • Investigators judged no serious adverse events related to study medication.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Neurology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Neurology Articles

Last month's top read Top Articles of 2013

1 Tremor JAMA, March 7, 2014    Review Article    Clinical Article

2 C-reactive protein as a prognostic marker after lacunar stroke Stroke, March 3, 2014    Clinical Article

3 Intakes of potassium, magnesium, and calcium and risk of stroke Stroke, March 25, 2014    Clinical Article

4 Long-term, serial screening for intracranial aneurysms in individuals with a family history of aneurysmal subarachnoid haemorrhage: A cohort study The Lancet Neurology, March 17, 2014    Review Article

5 Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation? Thrombosis and Haemostasis, January 17, 2014    Clinical Article

6 Statins and vascular dementia: A review Journal of Alzheimer’s Disease, March 27, 2014    Review Article

7 Risk and benefit of statins in stroke secondary prevention Current Vascular Pharmacology, March 26, 2014    Review Article

8 Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease Parkinsonism & Related Disorders, March 3, 2014    Clinical Article

9 Primary Sjögren's syndrome and risk of ischemic stroke: A nationwide study Clinical Rheumatology, March 24, 2014    Clinical Article

10 Dabigatran for stroke prevention in nonvalvular atrial fibrillation: Focus in the geriatric population The Consultant Pharmacist, March 5, 2014    Clinical Article

11 Patients with epilepsy are at an increased risk of subsequent stroke: A population-based cohort study Seizure - European Journal of Epilepsy, March 14, 2014    Clinical Article

12 Antivitamin K drugs in stroke prevention Current Vascular Pharmacology, March 28, 2014    Clinical Article

13 Risk of stroke associated with nonsteroidal anti-inflammatory drugs Full Text Vascular Health and Risk Management, January 13, 2014    Free full text    Review Article    Clinical Article

14 Prevention opportunities for oral contraceptive–associated ischemic stroke Stroke, March 6, 2014    Clinical Article

15 Early treatment of hypertension in acute ischemic and intracerebral hemorrhagic stroke: Progress achieved, challenges, and perspectives Journal of the American Society of Hypertension, March 20, 2014    Review Article

16 Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study The Lancet Neurology, March 12, 2014    Clinical Article

17 Continuous antihypertensive therapy throughout the initial 24 hours of intracerebral hemorrhage Stroke, March 5, 2014    Clinical Article

18 A practical approach to neurologic evaluation in the intensive care unit Journal of Critical Care, March 3, 2014    Clinical Article

19 Acupuncture enhances effective connectivity between cerebellum and primary sensorimotor cortex in patients with stable recovery stroke Full Text Evidence-based Complementary and Alternative Medicine , March 14, 2014    Free full text    Clinical Article

20 Acupuncture modulates the functional connectivity of the default mode network in stroke patients Full Text Evidence-based Complementary and Alternative Medicine , March 13, 2014    Free full text    Clinical Article

Indexed Journals in Neurology: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injurymore

Other Topics in Neurology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close